Report workspace tools

NCT03146689COMPLETEDanonymous

Identifying Treatment Responders to a Topical Non-steroidal Anti-inflammatory Drug (NSAID) or Topical Capsaicin in Painful Knee Osteoarthritis: A Pilot Series of N-of-1 Trials

Sponsor

Source record

University of Nottingham

Phase

Source record

NA

Modality

AI-normalized

small molecule

Target

AI-normalized

Topical NSAID, Topical Capsaicin

Indication / condition

AI-normalized

Osteoarthritis, Knee

Intervention

Source record

Topical NSAID, Topical Capsaicin

Source & freshness

Source record

NCT ID

NCT03146689

Original source

ClinicalTrials.gov

Source last updated

Apr 18, 2019

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03146689

Title

Identifying Treatment Responders to a Topical Non-steroidal Anti-inflammatory Drug (NSAID) or Topical Capsaicin in Painful Knee Osteoarthritis: A Pilot Series of N-of-1 Trials

Sponsor

University of Nottingham

Status

COMPLETED

Phase

NA

Condition raw

Osteoarthritis, Knee

Condition normalized

Osteoarthritis, Knee

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Topical NSAID, Topical Capsaicin

Target normalized

Topical NSAID, Topical Capsaicin

Interventions

Topical NSAID, Topical Capsaicin

Public preview

Source record

Despite evidence that topical non-steroidal anti-inflammatory drugs (NSAIDs) and capsaicin are effective in osteoarthritis (OA), it is still unclear why they work for some people but not others. The investigators are undertaking an individual patient data (IPD) meta-analysis to identify responders according to patient characteristics, however, no studies report the presence of synovial hypertrophy or neuropathic-like pain. These two traits are of interest as they may be used to optimise the treatment effects of the two drugs which work via different mechanisms to reduce pain in OA. The investigators are therefore conducting this pilot n-of-1 trial series.

This pilot n-of-1 trial series will investigate whether a person with OA, who has a different balance between inflammatory and neuropathic pain, shows a preference between these mechanistically different treatments. The trial will also be used to offer recommendations on the use of n-of-1 trial series for individualised (precision) medicine in OA.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account

Create a free account first, then unlock a single report, buy credits or subscribe.